Scarica l'app Stockscreener
7.70
3.99%
-0.32
Dopo l'orario di chiusura:
7.75
0.05
+0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.02
Aprire:
$7.695
Volume 24 ore:
4.64M
Relative Volume:
0.92
Capitalizzazione di mercato:
$1.25B
Reddito:
$1.12B
Utile/perdita netta:
$440.30M
Rapporto P/E:
3.2346
EPS:
2.3805
Flusso di cassa netto:
$-251.02M
1 W Prestazione:
-13.97%
1M Prestazione:
-23.84%
6M Prestazione:
-19.37%
1 anno Prestazione:
+28.76%
Intervallo 1D:
$7.565
$7.91
Intervallo di 1 settimana:
$7.565
$8.955
Portata 52W:
$5.01
$11.97
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.70 | 1.25B | 1.12B | 440.30M | -251.02M | 2.3805 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Ripresa | H.C. Wainwright | Buy |
| 2025-08-20 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Iniziato | Citigroup | Sell |
| 2025-02-28 | Iniziato | BTIG Research | Buy |
| 2024-07-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Reiterato | B. Riley Securities | Buy |
| 2022-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-02 | Iniziato | Jefferies | Hold |
| 2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2022-02-22 | Ripresa | Jefferies | Buy |
| 2022-01-21 | Iniziato | Cowen | Outperform |
| 2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Reiterato | B. Riley FBR | Buy |
| 2020-06-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Reiterato | B. Riley FBR | Buy |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-08-14 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-11 | Iniziato | Oppenheimer | Outperform |
| 2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
Levels Update: Is Novavax Inc benefiting from interest rate changes2026 Sector Moves & Weekly Setup with ROI Potential - baoquankhu1.vn
Behavioral Patterns of NVAX and Institutional Flows - news.stocktradersdaily.com
Novavax, Inc. (NVAX) stock price, news, quote and history - Yahoo Finance UK
Novavax Inc stock: Biotech innovator or fading COVID play? - AD HOC NEWS
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax (NASDAQ:NVAX) Shares Down 5.4%Should You Sell? - MarketBeat
NVAX Stock Price, Quote & Chart | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Novavax Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Novavax Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Novavax (XTER:NVV1) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook - Yahoo Finance
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - MarketBeat
Novavax names Robert Walker as R&D head By Investing.com - Investing.com South Africa
Novavax Stock Crosses 200-Day Moving Average - National Today
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax names new R&D chief as previous leader departs after less than two years - bizjournals.com
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next - 24/7 Wall St.
Novavax, Inc. Announces Executive Changes - marketscreener.com
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development - citybiz
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Novavax names Robert Walker as R&D head - Investing.com
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Equity in earnings of Novavax, Inc. – BSESOF:NVV1 - TradingView
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Trades Down, Here Is Why - Yahoo Finance
Vanguard (NVAX) amends 13G/A, reports 0 shares after Jan 12, 2026 realignment - Stock Titan
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax (XSWX:NVAX) PB Ratio : (As of Mar. 26, 2026) - GuruFocus
Novavax (NVAX) Declines Sharply Compared to Overall Market: Key Information for Investors - Bitget
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Novavax Inc stock faces renewed scrutiny amid biotech sector volatility and pipeline updates - AD HOC NEWS
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
NVAX SEC FilingsNovavax Inc 10-K, 10-Q, 8-K Forms - Stock Titan
(NVAX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Novavax Inc. stock rises Monday, still underperforms market - marketwatch.com
Novavax Q2 2025 Earnings Preview - MSN
Wall Street Recap: Can Novavax Inc stock outperform in a bear marketTrade Entry Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Q3 Earnings Estimate for Novavax Issued By Zacks Research - MarketBeat
2 Healthcare Stocks to Target This Week and 1 That Underwhelm - The Globe and Mail
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations - Yahoo Finance
Aug Selloffs: Is Novavax Inc benefiting from interest rate changesMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
NVAX stock rises overnight ahead of Q4 print with Pfizer tailwinds — analyst warns of 20% crash - MSN
Novavax (NVAX) Shares Drop 1.23%: Key Information to Note - Bitget
Novavax (NVAX) Stock Moves -1.23%: What You Should Know - Yahoo! Finance Canada
Therapeutics Sector Q4 Results: Revenue Beats Amid Market Stability - IndexBox
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Novavax Inc Azioni (NVAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 07 '26 |
Option Exercise |
0.00 |
12,223 |
0 |
136,503 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 03 '26 |
Option Exercise |
0.00 |
43,167 |
0 |
145,130 |
| Jacobs John C | President and CEO |
Mar 03 '26 |
Option Exercise |
0.00 |
150,167 |
0 |
264,130 |
| O'Hara Elaine | EVP, Chief Strategy Officer |
Mar 03 '26 |
Option Exercise |
0.00 |
56,334 |
0 |
157,071 |
| Casey Mark J | EVP, Chief Legal Officer |
Mar 03 '26 |
Option Exercise |
0.00 |
37,500 |
0 |
101,445 |
| Draghia-Akli Ruxandra | EVP, Research & Development |
Mar 03 '26 |
Option Exercise |
0.00 |
26,667 |
0 |
34,876 |
| Jacobs John C | President and CEO |
Mar 01 '26 |
Option Exercise |
0.00 |
83,333 |
0 |
264,130 |
| Kelly James Patrick | EVP, CFO and Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
58,666 |
0 |
130,299 |
| O'Hara Elaine | EVP, Chief Strategy Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
59,600 |
0 |
111,706 |
| Casey Mark J | EVP, Chief Legal Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
4,000 |
0 |
65,159 |
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):